Health
Convalescent plasma treatment added to Australian COVID-19 trials – Medical Xpress
Convalescent plasma has been introduced to the AustralaSian COVID-19 Trial (ASCOT) and Randomized, Embedded, Multi-factorial, Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP) clinical trials in a bid to identify the best strategy to treat …
Convalescent plasma has been introduced to the AustralaSian COVID-19 Trial (ASCOT) and Randomized, Embedded, Multi-factorial, Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP) clinical trials in a bid to identify the best strategy to treat patients hospitalized with COVID-19.
The first patient was recruited to ASCOT earlier this week at The Royal Melbourne Hospital, while REMAP-CAP is on schedule to recruit critically ill patients in partnering Intensive Care Units in the com…
-
General22 hours agoEmergency operation underway after reports of bodies north-east of Falls Creek
-
Noosa News22 hours agoMan arrested after gaining ‘unauthorised’ access to Amberley RAAF base
-
Noosa News24 hours agoPSPA declared, Camp Mountain – Sunshine Coast
-
Noosa News23 hours agoExclusion zone declared as bushfire sparks major emergency response near Brisbane